To evaluate the serum fibrinogen/albumin ratios in patients with acute and chronic central serous chorioretinopathy, and healthy control samples.
Methods
Serum fibrinogen/albumin ratios were assessed in patients with acute (Group-1, 30 eyes) and chronic (Group-2, 30 eyes) central serous chorioretinopathy, and compared with healthy control (Group-3, 30 eyes) samples.
Results
Fibrinogen/albumin ratios were significantly higher in Group-1 (104.72 ± 12.34) than in Group-2 (75.83 ± 10.06) and in Group-3 (72 ± 9.54) (p = 0.001). No significant correlation was found between age, CMT, and BCVA with fibrinogen/albumin ratios in the Pearson correlation analysis. In the ROC curve analysis, the most appropriate cut-off value of the fibrinogen/albumin ratio for acute CSCR was ≥87.8 and the optimal cut-off value for the fibrinogen/albumin ratio for chronic CSCR was ≥68.6.
Conclusion
The fibrinogen/albumin ratio may be useful as an inflammatory biomarker to monitor the systemic inflammatory state during the treatment and follow-up in patients with acute CSCR.
WangMMunchICHaslerPW, et al.Central serous chorioretinopathy. Acta Ophthalmol (Copenh)2008; 86: 126–145.
2.
NicholsonBNobleJForooghianF, et al.Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol2013; 58: 103–126.
3.
KayeRChandraSShethJ, et al.Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res2020; 79: 100865.
4.
DaruichAMatetABehar-CohenF. Central serous chorioretinopathy. Dev Ophthalmol2017; 58: 27–38.
5.
KitzmannASPulidoJSDiehlNN, et al.The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002. Ophthalmology2008; 115: 169–173.
6.
SahooNKGovindhariVBediR, et al.Subretinal hyperreflective material in central serous chorioretinopathy. Indian J Ophthalmol2020; 68: 126–129.
7.
SartiniFFigusMNardiM, et al.Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options. Eye (Lond)2019; 33: 1035–1043.
8.
DaruichAMatetADiraniA, et al.Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res2015; 48: 82–118.
9.
FieldMGElnerVMParkS, et al.Detection of retinal metabolic stress resulting from central serous retinopathy. Retina2009; 29: 1162–1166.
10.
TittlMKSpaideRFWongD, et al.Systemic findings associated with central serous chorioretinopathy. Am J Ophthalmol1999; 128: 63–68.
11.
WeiselJW. Fibrinogen and fibrin. Adv Protein Chem2005; 70: 247–299.
12.
DavalosDAkassoglouK. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol2012; 34: 43–62.
13.
MosessonMW. Fibrinogen and fibrin structure and functions. J Thromb Haemost2005; 3: 1894–1904.
14.
HoppeBDornerT. Coagulation and the fibrin network in rheumatic disease: a role beyond hemostasis. Nat Rev Rheumatol2012; 8: 738–746.
15.
PetersenMARyuJKAkassoglouK. Fibrinogen in neurological diseases: mechanisms, imaging, and therapeutics. Nat Rev Neurosci2018; 19: 283–301.
16.
ZhangCChenHHeQ, et al.Fibrinogen/AKT/microfilament axis promotes colitis by enhancing vascular permeability. Cell Mol Gastroenterol Hepatol2021; 11: 683–696.
17.
ArtigasAWernermanJArroyoV, et al.Role of albumin in diseases associated with severe systemic inflammation: pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis. J Crit Care2016; 33: 62–70.
18.
EckartAStrujaTKutzA, et al.Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med2020; 133: 713–722.
19.
ZhangYXiaoG. Prognostic significance of the ratio of fibrinogen and albumin in human malignancies: a meta-analysis. Cancer Manage Res2019; 11: 3381–3393.
20.
BiXSuZYanH, et al.Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count. Platelets2020; 31: 674–679.
21.
XiaoLJiaYWangX,et al.The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin Chim Acta2019; 493: 8–13.
22.
ZhangJDingYWangW, et al.Combining the fibrinogen/albumin ratio and systemic inflammation response Index predicts survival in resectable gastric cancer. Gastroenterol Res Pract2020; 25: 3207345.
23.
LoikeJDSilversteinRWrightS, et al.The role of protected extracellular compartments in interactions between leukocytes, and platelets, and fibrin/fibrinogen matrices. Ann NY Acad Sci1992; 667: 163–172.
24.
XuQYanYGuS, et al.A novel inflammation-based prognostic score: the fibrinogen/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. J Immunol Res2018; 2018: 4925498.
25.
TanZZhangMHanQ, et al.A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin Ratio. J Cancer2017; 8: 1025–1029.
26.
GucluHOzalSGurluV, et al.Increased fibrinogen to albumin ratio in ischemic retinal vein occlusions. Eur J Ophthalmol2017; 27: 735–739.
27.
KarahanOAcetHErtasF, et al.The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI. Am J Emerg Med2016; 34: 1037–1042.
28.
CayirSKayabasiSHizliO. Predictor parameters for poor prognosis in patients with sudden sensorineural hearing loss: fibrinogen to albumin ratio vs C-reactive protein to albumin ratio. Braz J Otorhinolaryngol2021; 87: 457–461.
29.
SzabaFMSmileySTRoles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood2002; 99: 1053–1051.
IijimaHLidaTMurayamaK, et al.Plasminogen activator inhibitor 1 in central serous chorioretinopathy. Am J Ophthalmol1999; 127: 477–478.
32.
SariEYaziciAEserB, et al.The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels. Cutan Ocul Toxicol2014; 33: 270–274.
33.
MalleEPertlLRennerW, et al.Role of the tissue-type plasminogen activator −7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy. Ophthalmic Genet2018; 39: 714–716.
34.
Karska-BastaIPociej-MarciakWChrząszczM, et al.Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy. Acta Ophthalmol2021; 99: 222–231.
35.
LiuMHuangYHuangZ, et al.The role of fibrinogen to albumin ratio in ankylosing spondylitis: correlation with disease activity. Clin Chim Acta2020; 505: 136–140.
36.
SirakayaEDuruZKuçukB,et al.Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy. Indian J Ophthalmol2020; 68: 854–858.
